Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.71 USD
Change Today +0.01 / 1.43%
Volume 8.6K
RBCL On Other Exchanges
Symbol
Exchange
OTC US
As of 2:00 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

rbc life sciences inc (RBCL) Snapshot

Open
$0.71
Previous Close
$0.70
Day High
$0.71
Day Low
$0.71
52 Week High
09/18/14 - $1.85
52 Week Low
03/6/15 - $0.45
Market Cap
1.6M
Average Volume 10 Days
817.3
EPS TTM
$-0.46
Shares Outstanding
2.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for RBC LIFE SCIENCES INC (RBCL)

Related News

No related news articles were found.

rbc life sciences inc (RBCL) Related Businessweek News

No Related Businessweek News Found

rbc life sciences inc (RBCL) Details

RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company’s Nutritional Products segment offers nutritional supplements and personal care products, including herbs, vitamins, and minerals; and natural skin, hair, and body care products through a network of independent distributors and license arrangements. Its products include Stem-Kine, a dietary supplement; Microhydrin and Microhydrin Plus antioxidants; VitAloe, a blend of research-backed ingredients; OliViva, an antioxidant beverage to support immune and cardiovascular system; Organic Spirulina, a nutritious alga that provides range of nutrients and easily digested proteins; and NeuroBright to support brain function, and enhance energy and acuity. This segments products also comprise Colo-Vada Plus, a colon cleansing program; HydraCel to enhance the quality of drinking water; 24 Seven, a multivitamin/mineral supplement; Immune 360 to nourish and support the function of the immune system; and Aloe Gelee gel that provides the soothing and moisturizing. Its Medical Products segment offers wound care products for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions. Its products include cleansers, dressings, hydrogels, collagen, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine. This segment also offers other wound care products designed to reduce destruction to skin and tissue caused by radiation; and to reduce pain and itching in the skin, and the internal mucosa caused by radiation reactions or reactions to various cancer medications. This segment sells its products under the MPM Medical brand to hospitals, nursing homes, clinics, and pharmacies through a network of medical/surgical supply dealers and pharmaceutical distributors. The company was founded in 1988 and is headquartered in Irving, Texas.

89 Employees
Last Reported Date: 03/31/15
Founded in 1988

rbc life sciences inc (RBCL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $280.0K
Founder and Chairman
Total Annual Compensation: $301.0K
Vice President of Operations
Total Annual Compensation: $138.0K
Compensation as of Fiscal Year 2014.

rbc life sciences inc (RBCL) Key Developments

RBC Life Sciences, Inc. Approves Resignation of Robert A. Kaiser as a Director

RBC Life Sciences Inc. approved resignation of Robert A. Kaiser as a director of the company at annual meeting of shareholders on June 24, 2015. Kaiser served as chair of the audit committee and as member of the compensation committee.

RBC Life Sciences Inc., Annual General Meeting, Jun 24, 2015

RBC Life Sciences Inc., Annual General Meeting, Jun 24, 2015., at 10:00 Central Standard Time. Location: 2301 Crown Court. Agenda: To elect two persons to serve as Class II directors of the company until the earlier of the 2018 Annual Meeting of Shareholders, their successors are duly elected and qualified, or their resignation or removal from office; to ratify the appointment of Lane Gorman Trubitt, PLLC as the company's independent registered public accounting firm for the fiscal year ending December 31, 2015; and to transact such other business as may properly come before the meeting or any adjournment thereof.

RBC Life Sciences Inc. Announces Executive Changes

RBC Life Sciences Inc. announced that effective January 1, 2015, the board of directors of the company appointed Mr. Steven E. Brown, to serve as the company's chief executive officer and president. Prior to this appointment, Mr. Brown served as the company's president. In his capacity as CEO, Mr. Brown replaces Clinton H. Howard, whose resignation as CEO became effective January 1, 2015. Mr. Howard will continue to serve as the company's chairman of the board.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RBCL:US $0.71 USD +0.01

RBCL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RBCL.
View Industry Companies
 

Industry Analysis

RBCL

Industry Average

Valuation RBCL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.1x
Price/Book 0.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RBC LIFE SCIENCES INC, please visit www.rbclifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.